Xueyan Liao

496 total citations
20 papers, 390 citations indexed

About

Xueyan Liao is a scholar working on Epidemiology, Infectious Diseases and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Xueyan Liao has authored 20 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Infectious Diseases and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Xueyan Liao's work include Hepatitis B Virus Studies (8 papers), Viral gastroenteritis research and epidemiology (6 papers) and Viral Infections and Immunology Research (6 papers). Xueyan Liao is often cited by papers focused on Hepatitis B Virus Studies (8 papers), Viral gastroenteritis research and epidemiology (6 papers) and Viral Infections and Immunology Research (6 papers). Xueyan Liao collaborates with scholars based in China, United States and India. Xueyan Liao's co-authors include Zhenglun Liang, Xiaohong Li, Shaobing Zhou, Heming Li, Xianmo Deng, Zhaojun Mo, Qiong Shou, Rongcheng Li, Yanping Li and Yun Zhao and has published in prestigious journals such as Journal of Controlled Release, Journal of Medicinal Chemistry and Vaccine.

In The Last Decade

Xueyan Liao

20 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xueyan Liao China 11 162 143 114 93 54 20 390
P Orsolini Italy 12 175 1.1× 104 0.7× 96 0.8× 20 0.2× 48 0.9× 31 423
B Scarpa Italy 8 267 1.6× 123 0.9× 154 1.4× 16 0.2× 77 1.4× 17 395
Nasir Mohajel Iran 10 28 0.2× 115 0.8× 19 0.2× 32 0.3× 36 0.7× 30 401
Е. Б. Файзулоев Russia 9 62 0.4× 118 0.8× 12 0.1× 27 0.3× 27 0.5× 49 268
Martina Sombetzki Germany 11 153 0.9× 56 0.4× 134 1.2× 24 0.3× 14 0.3× 33 476
Ran Jia China 13 235 1.5× 320 2.2× 22 0.2× 62 0.7× 48 0.9× 31 549
C Bach France 10 157 1.0× 146 1.0× 101 0.9× 18 0.2× 59 1.1× 21 373
Kaja Zuwała Denmark 14 69 0.4× 152 1.1× 24 0.2× 15 0.2× 54 1.0× 17 407
Ricardo Alberto Moliterno Brazil 15 140 0.9× 116 0.8× 77 0.7× 24 0.3× 145 2.7× 39 500
Shuyi He China 12 185 1.1× 181 1.3× 67 0.6× 14 0.2× 29 0.5× 22 344

Countries citing papers authored by Xueyan Liao

Since Specialization
Citations

This map shows the geographic impact of Xueyan Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueyan Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueyan Liao more than expected).

Fields of papers citing papers by Xueyan Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueyan Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueyan Liao. The network helps show where Xueyan Liao may publish in the future.

Co-authorship network of co-authors of Xueyan Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Xueyan Liao. A scholar is included among the top collaborators of Xueyan Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueyan Liao. Xueyan Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lv, Huakun, Shenyu Wang, Zhenzhen Liang, et al.. (2022). Immunogenicity and safety of the 9-valent human papillomavirus vaccine in Chinese females 9–45 years of age: A phase 3 open-label study. Vaccine. 40(23). 3263–3271. 10 indexed citations
2.
Liao, Xueyan, et al.. (2020). Slope displacement prediction method based on EEMD-PSO-ELM model. Zhongguo anquan kexue xuebao. 30(3). 157. 1 indexed citations
4.
Mo, Zhaojun, Xiao Ma, Peng Luo, et al.. (2019). Immunogenicity of pentavalent rotavirus vaccine in Chinese infants. Vaccine. 37(13). 1836–1843. 10 indexed citations
7.
Huang, Teng, Youping Liu, Yanping Li, et al.. (2018). Evaluation on the persistence of anti-HPV immune responses to the quadrivalent HPV vaccine in Chinese females and males: Up to 3.5 years of follow-up. Vaccine. 36(11). 1368–1374. 8 indexed citations
9.
Mo, Zhaojun, et al.. (2017). Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China. Human Vaccines & Immunotherapeutics. 13(6). 1272–1278. 7 indexed citations
10.
Tang, Yufeng, et al.. (2016). Failure criteria based on SPH slope stability analysis. Chinese Journal of Geotechnical Engineering. 38(5). 904–908. 2 indexed citations
11.
Li, Rongcheng, Teng Huang, Yanping Li, et al.. (2015). Immunogenicity and reactogenicity of the human rotavirus vaccine, RIX4414 oral suspension, when co-administered with routine childhood vaccines in Chinese infants. Human Vaccines & Immunotherapeutics. 12(3). 785–793. 13 indexed citations
12.
Liao, Xueyan & Zhenglun Liang. (2015). Strategy vaccination against Hepatitis B in China. Human Vaccines & Immunotherapeutics. 11(6). 0–0. 44 indexed citations
13.
Li, Rongcheng, Teng Huang, Yanping Li, et al.. (2013). Human rotavirus vaccine (RIX4414) efficacy in the first two years of life. Human Vaccines & Immunotherapeutics. 10(1). 11–18. 38 indexed citations
14.
Li, Rongcheng, Yanping Li, Zhaojun Mo, et al.. (2013). Reactogenicity and safety of a liquid human rotavirus vaccine (RIX4414) in healthy adults, children and infants in China. Human Vaccines & Immunotherapeutics. 9(8). 1638–1642. 8 indexed citations
16.
Yu, Dongmei, Ming Chen, & Xueyan Liao. (2011). Effects of antihypertensive drugs on expression of TRPC3 and TRPC6 in left ventricle of spontaneously hypertensive rats. International Journal of Cardiology. 152. S53–S53. 1 indexed citations
17.
Mao, Qunying, Xueyan Liao, Yu Xiang, et al.. (2010). Dynamic change of mother-source neutralizing antibodies against enterovirus 71 and coxsackievirus A16 in infants. Chinese Medical Journal. 123(13). 1679–1684. 21 indexed citations
18.
Yang, Hongzhen, Song Xu, Xueyan Liao, et al.. (2005). A Novel Immunostimulator,N2-[α-O-Benzyl-N-(acetylmuramyl)-l-alanyl-d- isoglutaminyl]-N6-trans-(m-nitrocinnamoyl)-l-lysine, and Its Adjuvancy on the Hepatitis B Surface Antigen. Journal of Medicinal Chemistry. 48(16). 5112–5122. 19 indexed citations
19.
Zhou, Shaobing, Xueyan Liao, Zhenglun Liang, et al.. (2004). Preparation and Characterization of Biodegradable Microspheres Containing Hepatitis B Surface Antigen. Macromolecular Bioscience. 4(1). 47–52. 10 indexed citations
20.
Zhou, Shaobing, Xueyan Liao, Xiaohong Li, Xianmo Deng, & Heming Li. (2003). Poly-d,l-lactide–co-poly(ethylene glycol) microspheres as potential vaccine delivery systems. Journal of Controlled Release. 86(2-3). 195–205. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026